Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies

Neuroscience

Volumn 167, Issue 3, 2010, Pages 929-945

  Iyer, A M ^a   Zurolo, E ^a   Boer, K ^a   Baayen, J C ^b   Giangaspero, F ^c,d   Arcella, A ^d   Di Gennaro, G C ^d   Esposito, V ^d,e   Spliet, W G M ^f   van Rijen, P C ^f   Troost, D ^a   Gorter, J A ^g,h   Aronica, E ^a,h  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d IRCCS NEUROMED   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

^h STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

Epilepsy; Focal cortical dysplasia; Ganglioglioma; Hippocampal sclerosis; Tuberous sclerosis

Indexed keywords

PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTE; CELLULAR DISTRIBUTION; CHILD; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM; EPILEPSY; EPILEPTOGENESIS; GENE EXPRESSION; GENE INDUCTION; GLIA CELL; HIPPOCAMPAL SCLEROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MICROGLIA; NERVE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUBEROUS SCLEROSIS; UPREGULATION; WESTERN BLOTTING;

ADOLESCENT; ADULT; ASTROCYTES; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BRAIN; BRAIN NEOPLASMS; CHILD; EPILEPSY; FEMALE; GANGLIOGLIOMA; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; MICROGLIA; MIDDLE AGED; NERVOUS SYSTEM MALFORMATIONS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE PLASMINOGEN ACTIVATOR; TUBEROUS SCLEROSIS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; YOUNG ADULT;

EID: 77951281887     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.02.047     Document Type: Article

References (96)

1. Alfano D., Franco P., Vocca I., Gambi N., Pisa V., Mancini A., Caputi M., Carriero M.V., Iaccarino I., Stoppelli M.P. The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis. Thromb Haemost 2005, 93:205-211. [see comment].
2. Alonso-Nanclares L., Garbelli R., Sola R.G., Pastor J., Tassi L., Spreafico R., DeFelipe J. Microanatomy of the dysplastic neocortex from epileptic patients. Brain 2005, 128:158-173.
3. Aronica E., Boer K., Becker A., Redeker S., Spliet W.G., van Rijen P.C., Wittink F., Breit T., Wadman W.J., Lopes da Silva F.H., Troost D., Gorter J.A. Gene expression profile analysis of epilepsy-associated gangliogliomas. Neuroscience 2008, 151:272-292.
4. Aronica E., Boer K., van Vliet E.A., Baayen J.C., Redeker S., Spliet W.G.M., Lopes da Silva F.H., Wadman W.J., Troost D., Gorter J.A. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 2007, 26:497-511.
5. Aronica E., Catania M.V., Geurts J., Yankaya B., Troost B. Immunohistochemical localization of Group I and II metabotropic glutamate receptors in control and ALS human spinal cord: upregulation in reactive astrocytes. Neuroscience 2001, 105:509-520.
6. Aronica E., Gorter J.A., Ramkema M., Redeker S., Ozbas-Gerceker F., van Vliet E.A., Scheffer G.L., Scheper R.J., van der Valk P., Baayen J.C., Troost D. Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia 2004, 45:441-451.
7. Aronica E., Gorter J.A., Redeker S., Ramkema M., Spliet W.G., van Rijen P.C., Leenstra S., Troost D. Distribution, characterization and clinical significance of microglia in glioneuronal tumours from patients with chronic intractable epilepsy. Neuropathol Appl Neurobiol 2005, 31:280-291.
8. Aronica E., Leenstra S., Jansen G.H., van Veelen C.W., Yankaya B., Troost D. Expression of brain-derived neurotrophic factor and tyrosine kinase B receptor proteins in glioneuronal tumors from patients with intractable epilepsy: colocalization with N-methyl-D-aspartic acid receptor. Acta Neuropathol 2001, 101:383-392.
9. Aronica E.M., Leenstra S., Jansen G., van Veelen C.W., Yankaya B., Troost D. Expression of BDNF and tyrosine kinase B (TrkB) receptor proteins in glioneuronal tumors from patients with intractable epilepsy: colocalization with NMDA receptor. Acta Neuropathol 2001, 101:383-392.
10. Barkovich A.J., Kuzniecky R.I., Jackson G.D., Guerrini R., Dobyns W.B. A developmental and genetic classification for malformations of cortical development. Neurology 2005, 65:1873-1887.
11. Benarroch E.E. Tissue plasminogen activator: beyond thrombolysis. Neurology 2007, 69:799-802.
12. Biermann J.C., Holzscheiter L., Kotzsch M., Luther T., Kiechle-Bahat M., Sweep F.C., Span P.N., Schmitt M., Magdolen V. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA. Int J Mol Med 2008, 21:251-259.
13. Blumcke I., Pauli E., Clusmann H., Schramm J., Becker A., Elger C., Merschhemke M., Meencke H.J., Lehmann T., von Deimling A., Scheiwe C., Zentner J., Volk B., Romstock J., Stefan H., Hildebrandt M. A new clinico-pathological classification system for mesial temporal sclerosis. Acta Neuropathol 2007, 113:235-244.
14. Blumcke I., Thom M., Wiestler O.D. Ammon's horn sclerosis: a maldevelopmental disorder associated with temporal lobe epilepsy. Brain Pathol 2002, 12:199-211.
15. Boer K., Crino P.B., Gorter J.A., Nellist M., Jansen F.E., Spliet W.G., van Rijen P.C., Wittink F., Breit T., Troost D., Wadman W.J., Aronica E. Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol 2009, 2009, Oct 8; [Epub ahead of print]; doi:10.1111/j.1750-3639.2009.00341.
16. Boer K., Jansen K., Nellist M., Redeker M., van den Ouweland A.M.W., Spliet W.G.M., van Nieuwenhuizen O., Troost D., Crino P.B., Aronica E. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res 2008, 78:7-21.
17. Boer K., Spliet W.G., van Rijen P.C., Redeker S., Troost D., Aronica E. Evidence of activated microglia in focal cortical dysplasia. J Neuroimmunol 2006, 173:188-195.
18. Brodsky S., Chen J., Lee A., Akassoglou K., Norman J., Goligorsky M.S. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis. Am J Physiol Heart Circ Physiol 2001, 281:H1784-H1792.
19. Carmeliet P., Collen D. Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system. Thromb Haemost 1995, 74:429-436.
20. Cepeda C., Andre V.M., Vinters H.V., Levine M.S., Mathern G.W. Are cytomegalic neurons and balloon cells generators of epileptic activity in pediatric cortical dysplasia?. Epilepsia 2005, 46:82-88.
21. Cepeda C., Hurst R.S., Flores-Hernandez J., Hernandez-Echeagaray E., Klapstein G.J., Boylan M.K., Calvert C.R., Jocoy E.L., Nguyen O.K., Andre V.M., Vinters H.V., Ariano M.A., Levine M.S., Mathern G.W. Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. J Neurosci Res 2003, 72:472-486.
22. Collen D. The plasminogen (fibrinolytic) system. Thromb Haemost 1999, 82:259-270.
23. Del Rosso M., Fibbi G., Pucci M., Margheri F., Serrati S. The plasminogen activation system in inflammation. Front Biosci 2008, 13:4667-4686.
24. Dent M.A., Sumi Y., Morris R.J., Seeley P.J. Urokinase-type plasminogen activator expression by neurons and oligodendrocytes during process outgrowth in developing rat brain. Eur J Neurosci 1993, 5:633-647.
25. Dityatev A., Fellin T. Extracellular matrix in plasticity and epileptogenesis. Neuron Glia Biol 2008, 4:235-247.
26. Eagleson K.L., Bonnin A., Levitt P. Region- and age-specific deficits in gamma-aminobutyric acidergic neuron development in the telencephalon of the uPAR(-/-) mouse. J Comp Neurol 2005, 489:449-466.
27. Fabbro S., Seeds N.W. Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain. J Neurochem 2009, 109:303-315.
28. Fabene P.F., Navarro M.G., Martinello M., Rossi B., Merigo F., Ottoboni L., Bach S., Angiari S., Benati D., Chakir A., Zanetti L., Schio F., Osculati A., Marzola P., Nicolato E., Homeister J.W., Xia L., Lowe J.B., McEver R.P., Osculati F., Sbarbati A., Butcher E.C., Constantin G. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 2008, 14:1377-1383. [see comment].
29. Faber-Elman A., Miskin R., Schwartz M. Components of the plasminogen activator system in astrocytes are modulated by tumor necrosis factor-alpha and interleukin-1beta through similar signal transduction pathways. J Neurochem 1995, 65:1524-1535.
30. Falcone D.J., McCaffrey T.A., Mathew J., McAdam K., Borth W. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor. J Cell Physiol 1995, 164:334-343.
31. Fernandez-Monreal M., Lopez-Atalaya J.P., Benchenane K., Leveille F., Cacquevel M., Plawinski L., MacKenzie E.T., Bu G., Buisson A., Vivien D. Is tissue-type plasminogen activator a neuromodulator?. Mol Cell Neurosci 2004, 25:594-601.
32. Gerritsen M.E., Niedbala M.J., Szczepanski A., Carley W.W. Cytokine activation of human macro- and microvessel-derived endothelial cells. Blood Cells 1993, 19:325-339. discussion 340-322.
33. Gomez M., Sampson J., Whittemore V. The tuberous sclerosis complex 1999, Oxford University Press, Oxford.
34. Gorter J.A., Van Vliet E., Aronica E., Rauwerda H., Breit T., Lopes da Silva F.H., Wadman W.J. Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J Neurosci 2006, 26:11083-11110.
35. Gorter J.A., Van Vliet E., Rauwerda H., Breit T., van Schaik L., Vreugdenhil E., Redeker S., Aronica E., Lopes da Silva F.H., Wadman W.J. Dynamic changes of proteases and protease inhibitors revealed by microarray analysis in CA3 and temporal lobe during epileptogenesis in the rat. Epilepsia 2007, 40:1-12.
36. Gravanis I., Tsirka S.E. Tissue plasminogen activator and glial function. Glia 2005, 49:177-183.
37. Gualandris A., Jones T.E., Strickland S., Tsirka S.E. Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator. J Neurosci 1996, 16:2220-2225.
38. Gveric D., Hanemaaijer R., Newcombe J., van Lent N.A., Sier C.F., Cuzner M.L. Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage. Brain 2001, 124:1978-1988.
39. Irigoyen J.P., Munoz-Canoves P., Montero L., Koziczak M., Nagamine Y. The plasminogen activator system: biology and regulation. Cell Mol Life Sci 1999, 56:104-132.
40. Kalderon N., Ahonen K., Fedoroff S. Developmental transition in plasticity properties of differentiating astrocytes: age-related biochemical profile of plasminogen activators in astroglial cultures. Glia 1990, 3:413-426.
41. Lahtinen L., Lukasiuk K., Pitkanen A. Increased expression and activity of urokinase-type plasminogen activator during epileptogenesis. Eur J Neurosci 2006, 24:1935-1945.
42. Lahtinen L., Huusko N., Myohanen H., Lehtivarjo A.K., Pellinen R., Turunen M.P., Yla-Herttuala S., Pirinen E., Pitkanen A. Expression of urokinase-type plasminogen activator receptor is increased during epileptogenesis in the rat hippocampus. Neuroscience 2009, 163:316-328.
43. Lahtinen L., Ndode-Ekane X.E., Barinka F., Akamine Y., Esmaeili M.H., Rantala J., Pitkänen A. Urokinase-type plasminogen activator regulates neurodegeneration and neurogenesis but not vascular changes in the mouse hippocampus after status epilepticus. Neurobiol Dis 2010, 37:692-703.
44. Larsson P., Ulfhammer E., Karlsson L., Bokarewa M., Wahlander K., Jern S. Effects of IL-1beta and IL-6 on tissue-type plasminogen activator expression in vascular endothelial cells. Thromb Res 2008, 123:342-351.
45. Levicar N., Nuttall R.K., Lah T.T. Proteases in brain tumour progression. Acta Neurochirurgica 2003, 145:825-838. [erratum appears in Acta Neurochir (Wien). 2003 Nov; 145(11):1023 Note: Nutall R K [corrected to Nuttall R K]].
46. Li X.F., Yan P.J., Shao Z.M. Downregulation of Mir-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Oncogene 2009, 28:3937-3948.
47. Lijnen H.R., Nelles L., Van Hoef B., Demarsin E., Collen D. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator. J Biol Chem 1988, 263:19083-19091.
48. Lo E.H., Wang X., Cuzner M.L. Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res 2002, 69:1-9.
49. Loscher W. Animal models of drug-resistant epilepsy. Novartis Found Symp 2002, 243:149-159. discussion 159-166.
50. Louis D.N., Ohgaki H., Wiestler O.D., Cavanee W.K. WHO classification of tumours of the central nervous system 2007, IARC, Lyon.
51. Lukasiuk K., Kontula L., Pitkanen A. cDNA profiling of epileptogenesis in the rat brain. Eur J Neurosci 2003, 17:271-279.
52. Mandriota S.J., Seghezzi G., Vassalli J.D., Ferrara N., Wasi S., Mazzieri R., Mignatti P., Pepper M.S. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 1995, 270:9709-9716.
53. Masos T., Miskin R. Localization of urokinase-type plasminogen activator mRNA in the adult mouse brain. Brain Res Mol Brain Res 1996, 35:139-148.
54. Maupas-Schwalm F., Auge N., Robinet C., Cambus J.P., Parsons S.J., Salvayre R., Negre-Salvayre A. The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator. FASEB J 2004, 18:1398-1400.
55. Nakajima K., Tohyama Y., Kurihara T., Kohsaka S. Enhancement of urokinase-type plasminogen activator (uPA) secretion, but not that of substrate plasminogen (PGn), by rat microglia stimulated with neuronal conditioned medium. Neurosci Lett 2005, 378:13-17.
56. Niedbala M.J. Cytokine regulation of endothelial cell extracellular proteolysis. Agents Actions Suppl 1993, 42:179-193.
57. Oby E., Janigro D. The blood-brain barrier and epilepsy. Epilepsia 2006, 47:1761-1774.
58. Palmini A., Najm I., Avanzini G., Babb T., Guerrini R., Foldvary-Schaefer N., Jackson G., Luders H.O., Prayson R., Spreafico R., Vinters H.V. Terminology and classification of the cortical dysplasias. Neurology 2004, 62:S2-S8.
59. Pawlak R., Strickland S. Tissue plasminogen activator and seizures: a clot-buster's secret life. J Clin Invest 2002, 109:1529-1531. [comment].
60. Pepper M.S., Montesano R., Mandriota S.J., Orci L., Vassalli J.D. Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 1996, 49:138-162.
61. Pittman R.N., Ivins J.K., Buettner H.M. Neuronal plasminogen activators: cell surface binding sites and involvement in neurite outgrowth. J Neurosci 1989, 9:4269-4286.
62. Powell E.M., Campbell D.B., Stanwood G.D., Davis C., Noebels J.L., Levitt P. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci 2003, 23:622-631.
63. Rakic J.M., Maillard C., Jost M., Bajou K., Masson V., Devy L., Lambert V., Foidart J.M., Noel A. Role of plasminogen activator-plasmin system in tumor angiogenesis. Cell Mol Life Sci 2003, 60:463-473.
64. Ramakers C., Ruijter J.M., Deprez R.H., Moorman A.F. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 2003, 339:62-66.
65. Ravizza T., Boer K., Redeker S., Spliet W.G., van Rijen P.C., Troost D., Vezzani A., Aronica E. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 2006, 24:128-143.
66. Ravizza T., Gagliardi B., Noe F., Boer K., Aronica E., Vezzani A. Innate and adaptive immune mechanisms during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 2008, 29:142-160.
67. Reijerkerk A., Kooij G., van der Pol S.M., Leyen T., van Het Hof B., Couraud P.O., Vivien D., Dijkstra C.D., de Vries H.E. Tissue-type plasminogen activator is a regulator of monocyte diapedesis through the brain endothelial barrier. J Immunol 2008, 181:3567-3574.
68. Rigau V., Morin M., Rousset M.C., de Bock F., Lebrun A., Coubes P., Picot M.C., Baldy-Moulinier M., Bockaert J., Crespel A., Lerner-Natoli M. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain 2007, 130:1942-1956.
69. Rogister B., Leprince P., Pettmann B., Labourdette G., Sensenbrenner M., Moonen G. Brain basic fibroblast growth factor stimulates the release of plasminogen activators by newborn rat cultured astroglial cells. Neurosci Lett 1988, 91:321-326.
70. Royer-Zemmour B., Ponsole-Lenfant M., Gara H., Roll P., Leveque C., Massacrier A., Ferracci G., Cillario J., Robaglia-Schlupp A., Vincentelli R., Cau P., Szepetowski P. Epileptic and developmental disorders of the speech cortex: ligand/receptor interaction of wild-type and mutant SRPX2 with the plasminogen activator receptor uPAR. Hum Mol Genet 2008, 17:3617-3630.
71. Schmitt M., Chucholowski N., Busch E., Hellmann D., Wagner B., Goretzki L., Janicke F., Gunzler W.A., Graeff H. Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cells. Semin Thromb Hemost 1991, 17:291-302.
72. Seeds N.W., Basham M.E., Haffke S.P. Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene. Proc Natl Acad Sci U S A 1999, 96:14118-14123.
73. Siao C.J., Fernandez S.R., Tsirka S.E. Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury. J Neurosci 2003, 23:3234-3242.
74. Siao C.J., Tsirka S.E. Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. J Neurosci 2002, 22:3352-3358.
75. Smith H.W., Marshall C.J. Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol 2010, 11:23-36.
76. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal Biochem 1985, 150:76-85.
77. Teesalu T., Kulla A., Asser T., Koskiniemi M., Vaheri A. Tissue plasminogen activator as a key effector in neurobiology and neuropathology. Biochem Soc Trans 2002, 30:183-189.
78. Teesalu T., Kulla A., Simisker A., Siren V., Lawrence D.A., Asser T., Vaheri A. Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system. Thromb Haemost 2004, 92:358-368.
79. Thom M. Recent advances in the neuropathology of focal lesions in epilepsy. Expert Rev Neurother 2004, 4:973-984.
80. Tranque P., Robbins R., Naftolin F., Andrade-Gordon P. Regulation of plasminogen activators and type-1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes. Glia 1992, 6:163-171.
81. Tsirka S.E. Tissue plasminogen activator as a modulator of neuronal survival and function. Biochem Soc Trans 2002, 30:222-225.
82. Tsirka S.E., Gualandris A., Amaral D.G., Strickland S. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 1995, 377:340-344.
83. Tucker H.M., Kihiko-Ehmann M., Estus S. Urokinase-type plasminogen activator inhibits amyloid-beta neurotoxicity and fibrillogenesis via plasminogen. J Neurosci Res 2002, 70:249-255.
84. van Vliet E.A., da Costa Araújo S., Redeker S., van Schaik R., Aronica E., Gorter J.A. Long-lasting increased permeability of the blood-brain barrier may contribute to seizure progression in temporal lobe epilepsy. Brain 2007, 130:521-534.
85. Vandeputte D.A., Troost D., Leenstra S., Ijlst-Keizers H., Ramkema M., Bosch D.A., Baas F., Das N.K., Aronica E. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors. Glia 2002, 38:329-338.
86. Vezzani A., Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005, 46:1724-1743.
87. Vezzani A., Ravizza T., Balosso S., Aronica E. Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia 2008, 49(Suppl 2):24-32.
88. Wagner S.N., Atkinson M.J., Wagner C., Hofler H., Schmitt M., Wilhelm O. Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney. Histochem Cell Biol 1996, 105:53-60.
89. Wieser H.G. ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 2004, 45:695-714.
90. Wong M. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia 2008, 49:8-21.
91. Wu Y.P., Siao C.J., Lu W., Sung T.C., Frohman M.A., Milev P., Bugge T.H., Degen J.L., Levine J.M., Margolis R.U., Tsirka S.E. The tissue plasminogen activator (tPA)/ plasmin extracellular proteolytic system regulates seizure-induced hippocampal mossy fiber outgrowth through a proteoglycan substrate. J Cell Biol 2000, 148:1295-1304.
92. Wyler A.R., Dohan C., Schweitzer J.B., Berry A.D. A grading system for mesial temporal pathology (hippocampal sclerosis) from anterior temporal lobectomy. J Epilepsy 1992, 5:220-225.
93. Yamamoto M., Sawaya R., Mohanam S., Bindal A.K., Bruner J.M., Oka K., Rao V.H., Tomonaga M., Nicolson G.L., Rao J.S. Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res 1994, 54:3656-3661.
94. Yepes M., Sandkvist M., Moore E.G., Bugge T.H., Strickland D.K., Lawrence D.A. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest 2003, 112:1533-1540.
95. Ying Z., Babb T.L., Mikuni N., Najm I., Drazba J., Bingaman W. Selective coexpression of NMDAR2A/B and NMDAR1 subunit proteins in dysplastic neurons of human epileptic cortex. Exp Neurol 1999, 159:409-418.
96. Zhang Y., Pothakos K., Tsirka S.A. Extracellular proteases: biological and behavioral roles in the mammalian central nervous system. Curr Top Dev Biol 2005, 66:161-188.